5. Bruker Corporation (NASDAQ:BRKR)
Bruker Corp. dropped its share prices by 12.12 percent on Monday to end at $35.63 apiece following the announcement of disappointing preliminary results for the second quarter of the year.
In a statement, Bruker Corporation (NASDAQ:BRKR) said that revenues during the period were expected to settle at $795 million to $798 million, which suggests a flat performance from the same period last year.
Second quarter 2025 bookings reflected weak academic demand, as well as softness in the US biopharma market.
Non-GAAP earnings per share were also expected to settle between $0.32 and $0.34, representing a $0.19 per share decline year-over-year, including a $0.06 foreign currency headwind.
Following the release, investment firm Stifel maintained its “hold” recommendation for its stock with a price target of $48, or a 34.7-percent upside from its latest closing price.
Bruker Corporation (NASDAQ:BRKR) said official results are scheduled for release before market open on August 4, 2025.
4. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Arrowhead Pharmaceuticals fell by 12.23 percent on Monday to close at $14.71 apiece as investors turned cautious amid regulatory troubles faced by one of its partners, Sarepta Therapeutics.
Last week, the FDA ordered Sarepta Therapeutics to stop selling Elevidys drugs following the death of two patients while undergoing treatment. However, Sarepta defied the orders, saying that it would continue to ship the drug to the ambulant population.
Concerns spilled over to shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), which has an ongoing partnership with Sarepta for the development of four drug candidates, especially since a large chunk of its revenues in the last reported quarter was tied to its partnership with the latter.
In the last reported quarter, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) swung to a net income of $370.4 million from a net loss of $125.3 million in the same period last year.
Revenues stood at $542.7 million, all of which was tied to its license and collaboration agreement with Sarepta.
3. SharpLink Gaming Inc. (NASDAQ:SBET)
SharpLink Gaming extended its losing streak to a third consecutive day on Monday, losing 12.89 percent to close at $25.25 apiece as investors continued to take profits following last week’s surge.
On Wednesday last week, SharpLink Gaming Inc. (NASDAQ:SBET) announced that it is now the largest holder of Ethereum cryptocurrencies globally following the recent acquisition of 74,656 ETH, pushing its total ownership to 280,706. The assets were acquired between July 7 and 13 at a weighted average price of $2,852 each.
The transaction also coincided with SharpLink Gaming, Inc.’s (NASDAQ:SBET) successful raising of $413 million through the issuance of more than 24 million shares At-The-Market between July 7 and 11.
As of July 13, SharpLink Gaming, Inc. (NASDAQ:SBET) said approximately $257 million of the total proceeds have yet to be spent on ETH purchases.
2. Webull Corporation (NASDAQ:BULL)
Webull ended a three-day winning streak on Monday, dropping 13.44 percent to close at $14.62 apiece as investors started taking profits following the previous day’s surge.
In recent news, Webull Corporation (NASDAQ:BULL) announced the reintegration of cryptocurrency trading into its group platform as it eyes reintroducing crypto trading to its global customer base following its launch in Brazil last month.
Additional markets are also expected to take place, including making cryptocurrency trading available to its US customers through the Webull app by the end of the third quarter.
“The improving clarity of cryptocurrency regulations, both in the United States and internationally, underlies our decision to bring crypto trading back to our platform,” Webull Corporation (NASDAQ:BULL) President and CEO Anthony Denier said.
“With this consolidation, the company will be better positioned to meet the needs of our customers. We are excited about the evolution of the financial services industry as it begins to adopt blockchain technology, and we’ve already seen great success with our rollout in Brazil. We look forward to tapping additional markets this year,” he added.
